Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

334
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
334
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

326
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
326
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

209
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
209
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

197
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
197
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

190
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190
Autoimmune Disorders01:29

Autoimmune Disorders

1.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.

Pediatric rheumatology online journal·2026
Same author

Factors predicting the severity of gastrointestinal involvement in children with IgA vasculitis? A Turkish multicenter cohort study.

European journal of pediatrics·2026
Same author

Systemic JIA-Associated Lung Disease: A Multicenter Analysis of Clinical Features, Treatment Challenges, and Outcomes.

Pediatric pulmonology·2026
Same author

Impact of rheumatologic diseases on pediatric inflammatory bowel disease.

The Turkish journal of pediatrics·2026
Same author

Before calling it FMF: MEFV variants of uncertain significance in autoinflammatory disease.

Rheumatology (Oxford, England)·2026
Same author

Clinical course, complications and treatment outcomes in Still's disease: a 10-year single-centre cohort study.

RMD open·2026

Related Experiment Video

Updated: Dec 21, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

865

Clusters in Pediatric Rheumatic Diseases.

Erdal Sag1, Selcan Demir1, Seza Ozen2

  • 1Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey.

Current Rheumatology Reports
|May 22, 2020
PubMed
Summary
This summary is machine-generated.

Disease clusters in rheumatic conditions offer insights into common presentations and outcomes. Identifying these phenotypes aids in predicting comorbidities, disease progression, and treatment effectiveness for better patient management.

Keywords:
ANCA-associated vasculitisAdenosine deaminase 2 deficiencyBehcetClustersSLE

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

774
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.9K

Related Experiment Videos

Last Updated: Dec 21, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

865
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

774
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.9K

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Rheumatic diseases exhibit complex pathophysiology leading to diverse clinical presentations.
  • Specific patient groups, or phenotypes, often share common disease trajectories and outcomes.

Purpose of the Study:

  • To review and summarize known disease clusters within various rheumatological conditions.
  • To explore the clinical significance of identified phenotypes in rheumatic diseases.

Main Methods:

  • Review of existing literature on cluster analysis and phenotype identification in rheumatic diseases.
  • Analysis of reported clusters in Behcet disease, systemic lupus erythematosus (SLE), deficiency of ADA2 (DADA2), and ANCA-associated vasculitis.

Main Results:

  • Behcet disease shows five distinct clusters with associated clinical features.
  • Systemic lupus erythematosus (SLE) demonstrates antibody-phenotype and damage clusters.
  • Deficiency of ADA2 (DADA2) presents two phenotypes: vasculopathy and bone marrow failure.
  • ANCA-associated vasculitis is increasingly grouped by phenotype and antibody associations.

Conclusions:

  • Distinct disease clusters exist across several rheumatic conditions.
  • Phenotypic clustering may facilitate prediction of comorbidities, disease course, and treatment response.
  • Further research into disease clustering can refine diagnostic and therapeutic strategies in rheumatology.